SCHEDULE: Brandes Investment Partners Boosts Lensar Stake

Brandes Investment Partners, LP has amended its Schedule 13G filing to report beneficial ownership of 1,026,018 common shares in LENSAR, Inc., representing 8.5% of the class.

Summary

• Brandes Investment Partners, L.P. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of LENSAR, Inc. common shares.
• As of September 30, 2025, the firm beneficially owns 1,026,018 shares.
• This ownership represents approximately 8.5% of the total class of securities.
• Brandes Investment Partners, L.P. has shared voting power over 937,207 shares and shared dispositive power over 1,026,018 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates continued or increased institutional interest from a significant investor, but lacks specific operational or financial performance details from the company itself.

Positives

• Brandes Investment Partners, L.P. has increased its stake or maintained a significant position in LENSAR, Inc., indicating confidence in the company's prospects.
• The ownership of 8.5% signifies a substantial investment, potentially leading to increased engagement and support for the company's strategy.

Negatives

• The filing does not contain specific financial performance data for LENSAR, Inc., making it difficult to assess the underlying business health.
• No details are provided regarding the specific reasons for the acquisition or the investment strategy behind this stake.

Risks

• The filing does not explicitly detail risks associated with LENSAR, Inc.'s business operations or market conditions.
• Potential risks for investors could include market volatility, competitive pressures in the medical device industry, and regulatory changes affecting LENSAR's products.

Future Outlook

The filing does not contain forward-looking statements or guidance from LENSAR, Inc. It solely reports the ownership stake of Brandes Investment Partners, L.P.

Management Comments

• Brandes Investment Partners, L.P. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported by Brandes Investment Partners, L.P. in LENSAR, Inc., often signals a belief in the company's long-term growth potential within the medical technology sector, particularly in areas like ophthalmic surgery.

Stakeholder Impact

• Shareholders: The increased or maintained stake by a significant institutional investor like Brandes Investment Partners, L.P. can be viewed positively, potentially signaling confidence and stability.
• Management: May face increased scrutiny or engagement from a substantial shareholder regarding company strategy and performance.
• Potential Investors: The filing provides transparency on a major shareholder, which can be a factor in investment decisions.

Next Steps

• Continue to monitor LENSAR, Inc.'s operational and financial performance disclosures.
• Observe any further changes in Brandes Investment Partners, L.P.'s ownership stake.

Key Dates

Keywords

LENSAR, Inc., Schedule 13G, Brandes Investment Partners, L.P., Beneficial Ownership, Common Shares, SEC Filing, Investment, Securities